3.17
price down icon5.65%   -0.19
 
loading
Schlusskurs vom Vortag:
$3.36
Offen:
$3.36
24-Stunden-Volumen:
2.65M
Relative Volume:
0.50
Marktkapitalisierung:
$57.04M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-43.27M
KGV:
-2.0584
EPS:
-1.54
Netto-Cashflow:
$-41.11M
1W Leistung:
-0.31%
1M Leistung:
+20.53%
6M Leistung:
-34.46%
1J Leistung:
-92.70%
1-Tages-Spanne:
Value
$3.00
$3.4278
1-Wochen-Bereich:
Value
$2.97
$3.85
52-Wochen-Spanne:
Value
$1.0404
$58.20

Biovie Inc Stock (BIVI) Company Profile

Name
Firmenname
Biovie Inc
Name
Telefon
775-888-3162
Name
Adresse
680 W NYE LANE, CARSON CITY
Name
Mitarbeiter
14
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
BIVI's Discussions on Twitter

Vergleichen Sie BIVI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
BIVI 3.17 57.04M 0 -43.27M -41.11M -1.54
VRTX 449.80 115.43B 10.63B -479.80M -1.35B 13.33
REGN 747.39 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 593.04 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 245.93 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.32 24.89B 3.30B -501.07M 1.03B 11.54

Biovie Inc Stock (BIVI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-07-22 Eingeleitet Cantor Fitzgerald Overweight
2021-01-15 Eingeleitet B. Riley Securities Buy

Biovie Inc Aktie (BIVI) Neueste Nachrichten

pulisher
Nov 20, 2024

Biovie Inc. to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long Covid At Theemystifying Long Covid International Conference - Marketscreener.com

Nov 20, 2024
pulisher
Nov 20, 2024

BioVie to Present Design of Planned Phase 2 Study of - GlobeNewswire

Nov 20, 2024
pulisher
Nov 20, 2024

BioVie's Long COVID Drug Trial Gets Pentagon Backing; Phase 2 Study to Include 200 Patients | BIVI Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 11, 2024

BioVie shareholders approve board nominees and equity plan expansion By Investing.com - Investing.com Canada

Nov 11, 2024
pulisher
Nov 11, 2024

BioVie shareholders approve board nominees and equity plan expansion - Investing.com India

Nov 11, 2024
pulisher
Nov 04, 2024

BioVie’s Upcoming Parkinson’s Disease Clinical Trial is Fully Funded - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

BioVie's Upcoming Parkinson's Disease Clinical Trial is Fully Funded - The Manila Times

Nov 04, 2024
pulisher
Oct 30, 2024

BioVie Raises Capital Through Direct Stock Offering - MSN

Oct 30, 2024
pulisher
Oct 29, 2024

BioVie Inc. Announces Closing of Registered Direct Offering - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

BioVie Raises $3.24 Million in Direct Offering - TipRanks

Oct 29, 2024
pulisher
Oct 29, 2024

BioVie sets price for $3.2 million stock offering By Investing.com - Investing.com Australia

Oct 29, 2024
pulisher
Oct 29, 2024

BioVie sets price for $3.2 million stock offering - Investing.com India

Oct 29, 2024
pulisher
Oct 29, 2024

BioVie prices stock offering at $2.83 per share By Investing.com - Investing.com Canada

Oct 29, 2024
pulisher
Oct 28, 2024

BIVIBioVie, Inc. Latest Stock News & Market Updates - StockTitan

Oct 28, 2024
pulisher
Oct 28, 2024

BioVie prices stock offering at $2.83 per share - Investing.com

Oct 28, 2024
pulisher
Oct 28, 2024

UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times

Oct 28, 2024
pulisher
Oct 28, 2024

BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times

Oct 28, 2024
pulisher
Oct 26, 2024

Short Interest in BioVie Inc. (NASDAQ:BIVI) Decreases By 51.0% - MarketBeat

Oct 26, 2024
pulisher
Oct 26, 2024

BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Carson City, Nevada, October 23, 2024 — BioVie Inc. (NASDAQ: BIVI), a clinical-stage company focused on developing innovative drug therapies for ch - Defense World

Oct 26, 2024
pulisher
Oct 24, 2024

BioVie Raises $6 Million in Strategic Funding - TipRanks

Oct 24, 2024
pulisher
Oct 24, 2024

BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement - StockTitan

Oct 24, 2024
pulisher
Oct 24, 2024

BioVie Announces $6 Million Stock Offering and Placement - TipRanks

Oct 24, 2024
pulisher
Oct 24, 2024

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Oct 24, 2024
pulisher
Oct 24, 2024

BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules - The Manila Times

Oct 24, 2024
pulisher
Oct 23, 2024

BioVie announces $6 million stock offering and warrants By Investing.com - Investing.com Australia

Oct 23, 2024
pulisher
Oct 23, 2024

BioVie announces $6 million stock offering and warrants - Investing.com India

Oct 23, 2024
pulisher
Oct 23, 2024

BioVie 2.667M share registered direct offering priced at $2.25 - TipRanks

Oct 23, 2024
pulisher
Oct 23, 2024

BioVie Inc. Announces Pricing of Registered Direct Offering - GlobeNewswire

Oct 23, 2024
pulisher
Oct 23, 2024

BioVie stock dips after pricing offering to raise $6.66M - MSN

Oct 23, 2024
pulisher
Oct 23, 2024

BioVie Announces Stock Offering and Private Placement - Yahoo Finance

Oct 23, 2024
pulisher
Oct 23, 2024

Join BioVie's Exclusive Live Investor Webinar and Q&A Session on November 7th, 2024 - The Manila Times

Oct 23, 2024
pulisher
Oct 23, 2024

Join BioVie’s Exclusive Live Investor Webinar and Q&A Session on November 7th, 2024 - GlobeNewswire

Oct 23, 2024
pulisher
Oct 23, 2024

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Oct 23, 2024
pulisher
Oct 22, 2024

BioVie announces $6.7 million direct stock offering - Investing.com India

Oct 22, 2024
pulisher
Oct 22, 2024

BioVie Secures $6.66 Million Through Direct Offering - TipRanks

Oct 22, 2024
pulisher
Oct 22, 2024

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Oct 22, 2024
pulisher
Oct 22, 2024

3 Penny Stocks to Watch Now, 10/22/24 - TipRanks

Oct 22, 2024
pulisher
Oct 22, 2024

BioVie stock dips after pricing offering to raise $6.66M (NASDAQ:BIVI) - Seeking Alpha

Oct 22, 2024
pulisher
Oct 22, 2024

BioVie announces $6.7 million direct stock offering By Investing.com - Investing.com Australia

Oct 22, 2024
pulisher
Oct 21, 2024

BioVie 4.443M share registered direct offering priced at $1.50 - TipRanks

Oct 21, 2024

Finanzdaten der Biovie Inc-Aktie (BIVI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):